These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25375959)

  • 1. Reperfusion of areas of ischemia in central retinal vein occlusion.
    Tan CS; Chew MC; Sadda SR
    JAMA Ophthalmol; 2015 Feb; 133(2):227-8. PubMed ID: 25375959
    [No Abstract]   [Full Text] [Related]  

  • 2. Reperfusion of areas of ischemia in central retinal vein occlusion - reply.
    Kamei M; Nishida K
    JAMA Ophthalmol; 2015 Feb; 133(2):228-9. PubMed ID: 25375096
    [No Abstract]   [Full Text] [Related]  

  • 3. Reperfusion of large ischemic areas associated with central retinal vein occlusion: a potential novel treatment with activated protein C.
    Kamei M; Matsumura N; Suzuki M; Sakimoto S; Sakaguchi H; Nishida K
    JAMA Ophthalmol; 2014 Mar; 132(3):361-2. PubMed ID: 24626830
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute central retinal vein occlusion successfully treated with intravenous thrombolysis.
    Costen MT; Donaldson WB; Olson JA
    Br J Ophthalmol; 1999 Oct; 83(10):1196-7. PubMed ID: 10636648
    [No Abstract]   [Full Text] [Related]  

  • 5. The rationale of retinal endovascular fibrinolysis in the treatment of retinal vein occlusion: from experimental data to clinical application.
    Pournaras CJ; Petropoulos IK; Pournaras JA; Stangos AN; Gilodi N; Rungger-Brändle E
    Retina; 2012 Sep; 32(8):1566-73. PubMed ID: 22466460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical and surgical management of central retinal vein occlusion.
    Sharma A; D'Amico DJ
    Int Ophthalmol Clin; 2004; 44(1):1-16. PubMed ID: 14704516
    [No Abstract]   [Full Text] [Related]  

  • 7. Retinal surgery for treatment of central retinal vein occlusion.
    Weiss JN
    Ophthalmic Surg Lasers; 2000; 31(2):162-5. PubMed ID: 10743932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual benefits of enoxaparin treatment in branch vein occlusion.
    Dragoni F; Kaarniranta K
    Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):1031-1033. PubMed ID: 29192333
    [No Abstract]   [Full Text] [Related]  

  • 9. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion.
    Lahey JM; Fong DS; Kearney J
    Ophthalmic Surg Lasers; 1999 Jun; 30(6):427-34. PubMed ID: 10392729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion.
    Hattenbach LO; Steinkamp G; Scharrer I; Ohrloff C
    Ophthalmologica; 1998; 212(6):394-8. PubMed ID: 9787229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated protein C rescues the retina from ischemia-induced cell death.
    Du ZJ; Yamamoto T; Ueda T; Suzuki M; Tano Y; Kamei M
    Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):987-93. PubMed ID: 20688738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.
    Squizzato A; Manfredi E; Bozzato S; Dentali F; Ageno W
    Thromb Haemost; 2010 Feb; 103(2):271-6. PubMed ID: 20126837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal endovascular lysis.
    Weiss JN
    Ophthalmology; 2008 Jan; 115(1):216-7; author reply 218. PubMed ID: 18166422
    [No Abstract]   [Full Text] [Related]  

  • 14. Surgical treatment of central retinal vein occlusion.
    Berker N; Batman C
    Acta Ophthalmol; 2008 May; 86(3):245-52. PubMed ID: 18494725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sulodexide treatment in retinal vein obstructions].
    Corbu C; Predoi D; Goicea D
    Oftalmologia; 1996; 40(4):393-7. PubMed ID: 8962873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [News in management of retinal vein occlusion].
    Bîscă M
    Oftalmologia; 2010; 54(3):51-7. PubMed ID: 21137190
    [No Abstract]   [Full Text] [Related]  

  • 17. Dalteparin versus aspirin in recent-onset branch retinal vein occlusion: a randomized clinical trial.
    Farahvash MS; Moradimogadam M; Farahvash MM; Mohammadzadeh S; Mirshahi A
    Arch Iran Med; 2008 Jul; 11(4):418-22. PubMed ID: 18588374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of thrombolytic agents during invasive treatments for retinal vascular occlusions].
    Sosnovskiĭ VV; Sdobnikova SV
    Vestn Oftalmol; 2007; 123(5):51-4. PubMed ID: 18078061
    [No Abstract]   [Full Text] [Related]  

  • 19. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study.
    Feltgen N; Junker B; Agostini H; Hansen LL
    Ophthalmology; 2007 Apr; 114(4):716-23. PubMed ID: 17141322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of local ophthalmic artery fibrinolysis in severe forms of central retinal vein occlusion].
    Vallée JN; Aymard A; Paques M; Santiago PY; Gaudric A; Merland JJ
    J Radiol; 2001 Feb; 82(2):137-44. PubMed ID: 11428208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.